Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells

REFERENCES

• Aaronson, D. S., and C. M. Horvath. 2002. A road map for those who don't know JAK-STAT. Science 296:1653–1655.
   PubMed Web of Science ®Google Scholar
• Amin, H. M., T. J. McDonnell, Y. Ma, Q. Lin, Y. Fujio, K. Kunisada, V. Leventaki, P. Das, G. Z. Rassidakis, C. Cutler, L. J. Medeiros, and R. Lai. 2004. Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene 23:5426–5434.
   PubMed Web of Science ®Google Scholar
• Balana, M. E., L. Labriola, M. Salatino, F. Movsichoff, G. Peters, E. H. Charreau, and P. V. Elizalde. 2001. Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells. Oncogene 20:34–47.
   PubMed Web of Science ®Google Scholar
• Balana, M. E., R. Lupu, L. Labriola, E. H. Charreau, and P. V. Elizalde. 1999. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas. Oncogene 18:6370–6379.
   PubMedGoogle Scholar
• Ballare, C., M. Uhrig, T. Bechtold, E. Sancho, M. Di Domenico, A. Migliaccio, F. Auricchio, and M. Beato. 2003. Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol. Cell. Biol. 23:1994–2008.
   PubMed Web of Science ®Google Scholar
• Boonyaratanakornkit, V., M. P. Scott, V. Ribon, L. Sherman, S. M. Anderson, J. L. Maller, W. T. Miller, and D. P. Edwards. 2001. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8:269–280.
   PubMed Web of Science ®Google Scholar
• Bowman, T., R. Garcia, J. Turkson, and R. Jove. 2000. STATs in oncogenesis. Oncogene 19:2474–2488.
   PubMed Web of Science ®Google Scholar
• Braunsberg, H., N. G. Coldham, R. E. Leake, S. K. Cowan, and W. Wong. 1987. Actions of a progestogen on human breast cancer cells: mechanisms of growth stimulation and inhibition. Eur. J. Cancer Clin. Oncol. 23:563–571.
   PubMedGoogle Scholar
• Bromberg, J., and J. E. Darnell, Jr. 2000. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468–2473.
   PubMed Web of Science ®Google Scholar
• Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem, and J. E. Darnell, Jr. 1998. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18:2553–2558.
   PubMed Web of Science ®Google Scholar
• Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell, Jr. 1999. Stat3 as an oncogene. Cell 98:295–303.
   PubMed Web of Science ®Google Scholar
• Burke, W. M., X. Jin, H. J. Lin, M. Huang, R. Liu, R. K. Reynolds, and J. Lin. 2001. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 20:7925–7934.
   PubMed Web of Science ®Google Scholar
• Castoria, G., M. V. Barone, M. Di Domenico, A. Bilancio, D. Ametrano, A. Migliaccio, and F. Auricchio. 1999. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18:2500–2510.
   PubMed Web of Science ®Google Scholar
• Catlett-Falcone, R., T. H. Landowski, M. M. Oshiro, J. Turkson, A. Levitzki, R. Savino, G. Ciliberto, L. Moscinski, J. L. Fernandez-Luna, G. Nunez, W. S. Dalton, and R. Jove. 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105–115.
   PubMed Web of Science ®Google Scholar
• Clarke, C. L., and R. L. Sutherland. 1990. Progestin regulation of cellular proliferation. Endocr. Rev. 11:266–301.
   PubMed Web of Science ®Google Scholar
• Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421.
   PubMed Web of Science ®Google Scholar
• Dechow, T. N., L. Pedranzini, A. Leitch, K. Leslie, W. L. Gerald, I. Linkov, and J. F. Bromberg. 2004. Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. Proc. Natl. Acad. Sci. USA 101:10602–10607.
   PubMed Web of Science ®Google Scholar
• De Miguel, F., S. O. Lee, S. A. Onate, and A. C. Gao. 2003. Stat3 enhances transactivation of steroid hormone receptors. Nucl. Recept. 1:3.
   PubMedGoogle Scholar
• Dran, G., I. A. Luthy, A. A. Molinolo, F. Montecchia, E. H. Charreau, C. D. Pasqualini, and C. Lanari. 1995. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma. Breast Cancer Res. Treat. 35:173–186.
   PubMedGoogle Scholar
• Garcia, R., T. L. Bowman, G. Niu, H. Yu, S. Minton, C. A. Muro-Cacho, C. E. Cox, R. Falcone, R. Fairclough, S. Parsons, A. Laudano, A. Gazit, A. Levitzki, A. Kraker, and R. Jove. 2001. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20:2499–2513.
   PubMed Web of Science ®Google Scholar
• Groshong, S. D., G. I. Owen, B. Grimison, I. E. Schauer, M. C. Todd, T. A. Langan, R. A. Sclafani, C. A. Lange, and K. B. Horwitz. 1997. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol. Endocrinol. 11:1593–1607.
   PubMed Web of Science ®Google Scholar
• Jing, N., Y. Li, W. Xiong, W. Sha, L. Jing, and D. J. Tweardy. 2004. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis. Cancer Res. 64:6603–6609.
   PubMed Web of Science ®Google Scholar
• Kaptein, A., V. Paillard, and M. Saunders. 1996. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J. Biol. Chem. 271:5961–5964.
   PubMedGoogle Scholar
• Kiss, R., R. J. Paridaens, J. C. Heuson, and A. J. Danguy. 1986. Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm. J. Natl. Cancer Inst. 77:173–178.
   PubMedGoogle Scholar
• Labriola, L., M. Salatino, C. J. Proietti, A. Pecci, O. A. Coso, A. R. Kornblihtt, E. H. Charreau, and P. V. Elizalde. 2003. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Mol. Cell. Biol. 23:1095–1111.
   PubMedGoogle Scholar
• Lange, C. A., J. K. Richer, T. Shen, and K. B. Horwitz. 1998. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways. J. Biol. Chem. 273:31308–31316.
   PubMed Web of Science ®Google Scholar
• Leonhardt, S. A., V. Boonyaratanakornkit, and D. P. Edwards. 2003. Progesterone receptor transcription and non-transcription signaling mechanisms. Steroids 68:761–770.
   PubMed Web of Science ®Google Scholar
• Li, L., and P. E. Shaw. 2002. Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines. J. Biol. Chem. 277:17397–17405.
   PubMed Web of Science ®Google Scholar
• Lin, V. C., R. Jin, P. H. Tan, S. E. Aw, C. T. Woon, and B. H. Bay. 2003. Progesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA. Am. J. Pathol. 162:1781–1787.
   PubMedGoogle Scholar
• Liu, T., and T. F. Ogle. 2002. Signal transducer and activator of transcription 3 is expressed in the decidualized mesometrium of pregnancy and associates with the progesterone receptor through protein-protein interactions. Biol. Reprod. 67:114–118.
   PubMed Web of Science ®Google Scholar
• Lydon, J. P., L. Sivaraman, and O. M. Conneely. 2000. A reappraisal of progesterone action in the mammary gland. J. Mammary Gland Biol. Neoplasia 5:325–338.
   PubMedGoogle Scholar
• Manni, A., B. Badger, C. Wright, S. R. Ahmed, and L. M. Demers. 1987. Effects of progestins on growth of experimental breast cancer in culture: interaction with estradiol and prolactin and involvement of the polyamine pathway. Cancer Res. 47:3066–3071.
   PubMed Web of Science ®Google Scholar
• Migliaccio, A., D. Piccolo, G. Castoria, M. Di Domenico, A. Bilancio, M. Lombardi, W. Gong, M. Beato, and F. Auricchio. 1998. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17:2008–2018.
   PubMed Web of Science ®Google Scholar
• Moore, M. R., J. L. Conover, and K. M. Franks. 2000. Progestin effects on long-term growth, death, and Bcl-xL in breast cancer cells. Biochem. Biophys. Res. Commun. 277:650–654.
   PubMed Web of Science ®Google Scholar
• Niu, G., R. Heller, R. Catlett-Falcone, D. Coppola, M. Jaroszeski, W. Dalton, R. Jove, and H. Yu. 1999. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res. 59:5059–5063.
   PubMed Web of Science ®Google Scholar
• Niu, G., K. H. Shain, M. Huang, R. Ravi, A. Bedi, W. S. Dalton, R. Jove, and H. Yu. 2001. Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res. 61:3276–3280.
   PubMed Web of Science ®Google Scholar
• Niu, G., K. L. Wright, M. Huang, L. Song, E. Haura, J. Turkson, S. Zhang, T. Wang, D. Sinibaldi, D. Coppola, R. Heller, L. M. Ellis, J. Karras, J. Bromberg, D. Pardoll, R. Jove, and H. Yu. 2002. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000–2008.
   PubMed Web of Science ®Google Scholar
• Olayioye, M. A., I. Beuvink, K. Horsch, J. M. Daly, and N. E. Hynes. 1999. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J. Biol. Chem. 274:17209–17218.
   PubMedGoogle Scholar
• Paukku, K., S. Valgeirsdottir, P. Saharinen, M. Bergman, C. H. Heldin, and O. Silvennoinen. 2000. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Biochem. J. 345(Pt. 3):759–766.
   PubMedGoogle Scholar
• Puricelli, L., C. J. Proiettii, L. Labriola, M. Salatino, M. E. Balana, G. J. Aguirre, R. Lupu, O. P. Pignataro, E. H. Charreau, J. E. Bal de Kier, and P. V. Elizalde. 2002. Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells. Int. J. Cancer 100:642–653.
   PubMed Web of Science ®Google Scholar
• Real, P. J., A. Sierra, A. De Juan, J. C. Segovia, J. M. Lopez-Vega, and J. L. Fernandez-Luna. 2002. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 21:7611–7618.
   PubMed Web of Science ®Google Scholar
• Ren, Z., and T. S. Schaefer. 2002. ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner. J. Biol. Chem. 277:38486–38493.
   PubMed Web of Science ®Google Scholar
• Richer, J. K., C. A. Lange, N. G. Manning, G. Owen, R. Powell, and K. B. Horwitz. 1998. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. J. Biol. Chem. 273:31317–31326.
   PubMed Web of Science ®Google Scholar
• Salatino, M., R. Schillaci, C. J. Proietti, R. Carnevale, I. Frahm, A. A. Molinolo, A. Iribarren, E. H. Charreau, and P. V. Elizalde. 2004. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Oncogene 23:5161–5174.
   PubMed Web of Science ®Google Scholar
• Sartor, C. I., M. L. Dziubinski, C. L. Yu, R. Jove, and S. P. Ethier. 1997. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res. 57:978–987.
   PubMed Web of Science ®Google Scholar
• Schaefer, L. K., S. Wang, and T. S. Schaefer. 2000. Oncostatin M activates stat DNA binding and transcriptional activity in primary human fetal astrocytes: low- and high-passage cells have distinct patterns of stat activation. Cytokine 12:1647–1655.
   PubMedGoogle Scholar
• Schulze, H., M. Ballmaier, K. Welte, and M. Germeshausen. 2000. Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human platelets. Exp. Hematol. 28:294–304.
   PubMed Web of Science ®Google Scholar
• Shen, T., K. B. Horwitz, and C. A. Lange. 2001. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol. Cell. Biol. 21:6122–6131.
   PubMed Web of Science ®Google Scholar
• Sherman, C. T., and A. R. Brasier. 2001. Role of signal transducers and activators of transcription 1 and 3 in inducible regulation of the human angiotensinogen gene by interleukin-6. Mol. Endocrinol. 15:441–457.
   PubMedGoogle Scholar
• Silvennoinen, O., C. Schindler, J. Schlessinger, and D. E. Levy. 1993. Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science 261:1736–1739.
   PubMed Web of Science ®Google Scholar
• Stoecklin, E., M. Wissler, D. Schaetzle, E. Pfitzner, and B. Groner. 1999. Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family. J. Steroid Biochem. Mol. Biol. 69:195–204.
   PubMed Web of Science ®Google Scholar
• Taga, T., and T. Kishimoto. 1997. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:797–819.
   PubMed Web of Science ®Google Scholar
• Vultur, A., J. Cao, R. Arulanandam, J. Turkson, R. Jove, P. Greer, A. Craig, B. Elliott, and L. Raptis. 2004. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene 23:2600–2616.
   PubMed Web of Science ®Google Scholar
• Wang, T., G. Niu, M. Kortylewski, L. Burdelya, K. Shain, S. Zhang, R. Bhattacharya, D. Gabrilovich, R. Heller, D. Coppola, W. Dalton, R. Jove, D. Pardoll, and H. Yu. 2004. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10:48–54.
   PubMed Web of Science ®Google Scholar
• Yu, H., and R. Jove. 2004. The STATs of cancer—new molecular targets come of age. Nat. Rev. Cancer 4:97–105.
   PubMed Web of Science ®Google Scholar
• Zhang, X., M. H. Wrzeszczynska, C. M. Horvath, and J. E. Darnell, Jr. 1999. Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation. Mol. Cell. Biol. 19:7138–7146.
   PubMedGoogle Scholar
• Zhang, Y., J. Turkson, C. Carter-Su, T. Smithgall, A. Levitzki, A. Kraker, J. J. Krolewski, P. Medveczky, and R. Jove. 2000. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. J. Biol. Chem. 275:24935–24944.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., S. Jones, J. S. Hagood, N. L. Fuentes, and G. M. Fuller. 1997. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J. Biol. Chem. 272:30607–30610.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., J. Bond, and P. Thomas. 2003. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc. Natl. Acad. Sci. USA 100:2237–2242.
   PubMed Web of Science ®Google Scholar